[email protected]/(408) 457-3700

About UE LifeSciences Inc

UELS is commercializing clinically effective, non-radiological tools operable by health-workers & primary care physicians to enable screening in emerging economies without western infrastructure. UELS innovations are also helpful for women that are underserved by the currently available solutions, such as women with dense breasts and women at high-risk for breast cancer. The Company has two products in its current portfolio; NoTouch BreastScan™ (NTBS) and iBreastExam™ (iBE). NTBS is an infrared based, touch-less and radiation-free breast-imaging tool that is US FDA cleared and CE marked for ‘Adjunctive Breast Cancer Screening’. 30+ units have been sold in India, Middle East, Latin-America and USA at an average sales price of $45,000/unit and 70% gross-margin. 3 clinical studies have been published in USA and UK. iBE is patented, hand-held and wireless breast scanner that enables primary care health workers to administer “CBE-like” breast exams, quickly and provides results at the point-of-care. iBE’s is production-ready and expected to receive FDA and CE before Q2 2015.

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
Philadelphia
Markets:
Medical Devices
Therapeutic Areas:
Women's Health